Top

Published in:

Open Access 01-12-2011 | Review

Septic cardiomyopathy

Author: Antoine Vieillard-Baron

Published in: Annals of Intensive Care | Issue 1/2011

Abstract

Depression of left ventricular (LV) intrinsic contractility is constant in patients with septic shock. Because most parameters of cardiac function are strongly dependent on afterload, especially in this context, the cardiac performance evaluated at the bedside reflects intrinsic contractility, but also the degree of vasoplegia. Recent advances in echocardiography have allowed better characterization of septic cardiomyopathy. It is always reversible providing the patient's recovery. Unlike classic cardiomyopathy, it is not associated with high filling pressures, for two reasons: improvement in LV compliance and associated right ventricular dysfunction. Although, it is unclear to which extent it affects prognosis, a hyperkinetic state is indicative of a profound and persistent vasoplegia associated with a high mortality rate. Preliminary data suggest that the hemodynamic response to a dobutamine challenge has a prognostic value, but large studies are required to establish whether inotropic drugs should be used to treat this septic cardiac dysfunction.

Available only for authorised users

Parker M, Shelhamer J, Bacharach S, Green M, Natanson C, Frederick T, Damske B, Parrillo J: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100: 483–490.PubMedCrossRef

Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdarias JP: Sepsis-related cardiogenic shock. Crit Care Med 1990, 18: 1055–1060. 10.1097/00003246-199010000-00001PubMedCrossRef

Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE: Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989, 83: 243–251. 10.1172/JCI113866PubMedCentralPubMedCrossRef

Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah A, Mebazaa A: Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007, 35: 1376–1382. 10.1097/01.CCM.0000261889.18102.84PubMedCrossRef

Vieillard-Baron A, Prin S, Chergui K, Dubourg O, Jardin F: Hemodynamic instability in sepsis. Bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 2003, 168: 1270–1276. 10.1164/rccm.200306-816CCPubMedCrossRef

Cunnion RE, Schaer GK, Parker MM, Natanson C, Parrillo JE: The coronary circulation in human septic shock. Circulation 1986, 73: 637–644.PubMedCrossRef

Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Avasantucci J, Brunet F, Villemant D, Carli A, Raichvarg D: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75: 533–541.PubMedCrossRef

Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985, 76: 1539–1553. 10.1172/JCI112135PubMedCentralPubMedCrossRef

Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE: Endotoxin and tumor necrosis factor challenges in dogs stimulate the cardiovascular profile of human septic shock. J Exp Med 1989, 169: 823–832. 10.1084/jem.169.3.823PubMedCrossRef

10.

Hollenberg SM, Cunnion RE, Lawrence M: Tumor necrosis factor depress myocardial cell function: results using an in vitro assay of myocyte performance. Clin Res 1989, 37: 528–534.

11.

Kumar A, Thota V, Dee L, Olson J, Parrillo JE: Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in-vitro myocardial cell contractility induced by serum from human septic shock. J Exp Med 1996, 183: 949–958. 10.1084/jem.183.3.949PubMedCrossRef

12.

Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F, Schulz R, Parrillo JE: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999, 276: R265-R276.PubMed

13.

Levy RJ, Piel DA, Acton PD: Evidence of myocardial hibernation in the septic heart. Crit Care Med 2005, 33: 2752–2756. 10.1097/01.CCM.0000189943.60945.77PubMedCrossRef

14.

Tavernier B, Li JM, El-Omar MM, Lanone S, Yang ZK, Trayer IP, Mebazaa A, Shah AM: Cardiac contractility impairment associated with increased phosphorylation of troponin I in endotoxemic rats. Faseb J 2001, 15: 294–296.PubMed

15.

Jardin F, Fourme T, Page B, Loubières Y, Vieillard-Baron A, Beauchet A, Bourdarias JP: Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 1999, 116: 1354–1359. 10.1378/chest.116.5.1354PubMedCrossRef

16.

Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby JJ: Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009, 37: 441–447. 10.1097/CCM.0b013e318194ac44PubMedCrossRef

17.

Vincent JL, Reuse C, Frank N, Contempré B, Kahn RJ: Right ventricular dysfunction in septic shock: assessment by measurements of right ventricular ejection fraction using thermodilution technique. Acta Anaesthesiol Scand 1989, 33: 34–38. 10.1111/j.1399-6576.1989.tb02856.xPubMedCrossRef

18.

Kimchi A, Ellrodt AG, Berman DS, Riedinger MS, Swan HJC, Murata GH: Right ventricular performance in septic shock: A combined radionuclide and hemodynamic study. J Am Coll Cardiol 1984, 4: 945–951. 10.1016/S0735-1097(84)80055-8PubMedCrossRef

19.

Parker MM, McCarthy KE, Ognibene FP, Parrillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990, 97: 126–131. 10.1378/chest.97.1.126PubMedCrossRef

20.

Vieillard-Baron A, Schmitt JM, Beauchet A, Augarde R, Prin S, Page B, Jardin F: Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001, 94: 400–406. 10.1097/00000542-200103000-00007PubMedCrossRef

21.

Schneider AJ, Teule GJ, Groeneveld AB, Nauta J, Heidendal GA, Thijs LG: Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J 1988, 116: 103–112. 10.1016/0002-8703(88)90256-6PubMedCrossRef

22.

Etchecopar-Chevreuil C, François B, Clavel M, Pichon N, Gastinne H, Vignon P: Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 2008, 34: 250–256. 10.1007/s00134-007-0929-zPubMedCrossRef

23.

Suffredini A, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321: 280–287. 10.1056/NEJM198908033210503PubMedCrossRef

24.

Robotham JL, Takata M, Berman M, Harasawa Y: Ejection fraction revisited. Anesthesiology 1991, 74: 172–183. 10.1097/00000542-199101000-00026PubMedCrossRef

25.

Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F: Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008, 36: 1701–1706. 10.1097/CCM.0b013e318174db05PubMedCrossRef

26.

Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D: Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34: 344–353. 10.1097/01.CCM.0000194725.48928.3APubMedCrossRef

27.

Boyd JH, Forbes J, Nakada TA, Walley K, Russel JA: Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39: 259–265. 10.1097/CCM.0b013e3181feeb15PubMedCrossRef

28.

Ognibene F, Parker M, Natanson C, Shelhamer J, Parrillo J: Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988, 93: 903–910. 10.1378/chest.93.5.903PubMedCrossRef

29.

Vincent JL, Roman A, Kahn RJ: Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med 1990, 18: 689–693. 10.1097/00003246-199007000-00001PubMedCrossRef

30.

Vallet B, Chopin C, Curtis SE, Dupuis BA, Fourrier F, Mehdaoui H, Leroy B, Rime A, Santre C, Herbecq : Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study. Crit Care Med 1993, 21: 1868–1875. 10.1097/00003246-199312000-00014PubMedCrossRef

31.

Rhodes A, Lamb FJ, Malagon I, Newman PJ, Grounds RM, Bennett ED: A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock. Crit Care Med 1999, 27: 2361–2366. 10.1097/00003246-199911000-00007PubMedCrossRef

32.

Kumar A, Schupp E, Bunnell E, Ali A, Milcarek B, Parrillo J: Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 2008, 12: R35. 10.1186/cc6814PubMedCentralPubMedCrossRef

33.

Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian N, Pietropaoli P: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005, 31: 638–644. 10.1007/s00134-005-2619-zPubMedCrossRef

34.

Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Carbone I, Tritapepe L, Pietropaoli P, Westpheal M: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006, 34: 2287–2293. 10.1097/01.CCM.0000230244.17174.4FPubMedCrossRef

35.

Hamzaoui O, Georger JF, Monnet X, Ksouri H, Maizel J, Richard C, Teboul JL: Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 2010, 14: R142. 10.1186/cc9207PubMedCentralPubMedCrossRef

Title: Septic cardiomyopathy
Author: Antoine Vieillard-Baron
Publication date: 01-12-2011
Publisher: Springer Paris
Published in: Annals of Intensive Care / Issue 1/2011
Electronic ISSN: 2110-5820
DOI: https://doi.org/10.1186/2110-5820-1-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Septic cardiomyopathy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Clinical detection and monitoring of acute pulmonary embolism: proof of concept of a computer-based method

The rising problem of antimicrobial resistance in the intensive care unit

Clinical applicability of functional hemodynamic monitoring

Training in critical care echocardiography

An integrated approach for prescribing fewer chest x-rays in the ICU

Renal and neurological side effects of colistin in critically ill patients